HEALTH OF WOMAN. 2015.9(105):74–76 

The interferon preparations in the treatment of acute respiratory viral infection in pregnant women of high risk group 

Limanskaya A., Davydova Iu.

SI «Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine», Kiev 

Currently in the practice of medicine commonly used drugs based on the interferons. Nazoferon (Farmak) is an effective and safe medication for prevention and treatment of acute respiratory viral infections, including those complicated by bacterial infection. The lack of systemic action, significant side effects, adverse effects on the fetus, in some cases – addressing the needs of women in the symptomatic therapy, allow its use in pregnant high-risk groups with acute respiratory viral infection and bacterial colonization of the nasopharynx. 

Key words: pregnancy, nazoferon, acute respiratory viral infection. 

REFERENCES

1. Осипова ЛС. 2011. Сучаснi препарати та технології 2(78):70–73.

2. Перетрухина АТ, Блинова ЕИ. 2010. Бактерийные и вирусные препараты. Академия Естествознания. www.rae.ru/monographs/137-4502.

3. Матвеев ВА, Шевцова ВВ. Генно-инженерный интерферон альфа-2В для местного применения (Лаферон-ФармБиотек назальный) в профилактике и лечении ОРВИ.

4. Kneyber MC, Moll HA, de Groot R. 2000. Treatment and prevention of respiratory virus infection. Eur. J. Pediatr. 159;6:399–411. http://dx.doi.org/10.1007/s004310051296

5. Karlberg H, Lindegren G, Mirazimi A. 2010. The open Virology J. 4:38–41.